Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma (Q34246444)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma |
scientific article |
Statements
1 reference
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma (English)
1 reference
Richard S Finn
1 reference
Yoon-Koo Kang
1 reference
Mary Mulcahy
1 reference
Blase N Polite
1 reference
Ho Yeong Lim
1 reference
Ian Walters
1 reference
Christine Baudelet
1 reference
Demetrios Manekas
1 reference
Joong-Won Park
1 reference
11 January 2012
1 reference
1 reference
Identifiers
1 reference